We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OTLK Outlook Therapeutics Inc

-0.0159 (-3.31%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,623,478
Bid Price 0.45
Ask Price 0.4728
News -
Day High 0.48


52 Week Range


Day Low 0.4573
Share Name Share Symbol Market Stock Type
Outlook Therapeutics Inc OTLK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0159 -3.31% 0.4641 18:17:50
Open Price Low Price High Price Close Price Previous Close
0.4752 0.4573 0.48 0.4728 0.48
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,739 1,623,478 US$ 0.4745002 US$ 770,341 - 0.2002 - 2.03
Last Trade Type Quantity Price Currency
18:11:15 formt 554 US$ 0.4641 USD

Outlook Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
122.32M 260.25M - 0 -66.05M -0.25 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Outlook Therapeutics News

Date Time Source News Article
11/29/202315:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
11/28/202304:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/27/202307:05GlobeNewswire Inc.Outlook Therapeutics® Announces Receipt of Type A Meeting..
11/21/202304:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/14/202307:05GlobeNewswire Inc.Outlook Therapeutics® Adds Global Commercial Expertise with..
11/14/202304:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/02/202307:12Edgar (US Regulatory)Form 8-K - Current report
11/02/202307:05GlobeNewswire Inc.Outlook Therapeutics® Provides Update on Type A Meetings..
11/01/202307:05GlobeNewswire Inc.Outlook Therapeutics® to Present at Guggenheim’s 5th Annual..
10/20/202316:00Edgar (US Regulatory)Form 8-K - Current report
10/05/202316:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/05/202316:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No OTLK Message Board. Create One! See More Posts on OTLK Message Board See More Message Board Posts

Historical OTLK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.45050.49820.44880.47535271,711,8920.01363.02%
1 Month0.340.53460.33940.4529583,652,1540.124136.5%
3 Months0.21540.900.20020.45501818,295,1030.2487115.46%
6 Months1.512.030.20020.54000256,515,671-1.05-69.26%
1 Year1.042.030.20020.59416123,596,740-0.5759-55.38%
3 Years1.224.260.20021.282,332,319-0.7559-61.96%
5 Years5.6020.000.20021.442,034,601-5.14-91.71%

Outlook Therapeutics Description

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |